Serum HER2 levels are increased in patients with chronic heart failure. (Q51794552)

12 April 2018

title

Serum HER2 levels are increased in patients with chronic heart failure. (English)

1 reference

12 April 2018

main subject

heart failure

0 references

chronic heart failure

1 reference

3

1 reference

12 April 2018

Dirk T. Sleijfer

6

object named as

Dirk T Sleijfer

1 reference

12 April 2018

Patrick J. Perik

1

object named as

Patrick J Perik

1 reference

12 April 2018

author name string

Elisabeth G E de Vries

2

1 reference

12 April 2018

Winette T A van der Graaf

4

1 reference

12 April 2018

Tom D J Smilde

5

1 reference

12 April 2018

Dirk J van Veldhuisen

7

1 reference

12 April 2018

publication date

24 July 2006

1 reference

12 April 2018

European Journal of Heart Failure

published in

1 reference

12 April 2018

volume

9

1 reference

12 April 2018

issue

2

1 reference

12 April 2018

page(s)

173-177

1 reference

12 April 2018

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.010

Requirement for neuregulin receptor erbB2 in neural and cardiac development

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.010

ErbB2 is essential in the prevention of dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.010

Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.010

Subcellular effects of adriamycin in the heart: a concise review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.010

Prognostic and predictive impact of the HER-2/ neu extracellular domain (ECD) in the serum of patients treated with chemotherapy for metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.010

Analysis of HER2 and HER4 in human myocardium to clarify the cardiotoxicity of trastuzumab (Herceptin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.010

Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes: implications for herceptin-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.010

Left ventricular unloading alters receptor tyrosine kinase expression in the failing human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.010

Neuregulin receptors erbB2 and erbB4 in failing human myocardium -- depressed expression and attenuated activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.010

10.1016/J.EJHEART.2006.05.010

21 January 2018

Identifiers

DOI

1 reference

12 April 2018

1 reference

12 April 2018